| Original language | English |
|---|---|
| Pages (from-to) | 65-69 |
| Number of pages | 5 |
| Journal | Journal of Clinical Lipidology |
| Volume | 3 |
| Issue number | 2 |
| DOIs |
|
| State | Published - Apr 2009 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
The use of niacin† . / Brown, W. Virgil; Goldberg, Anne C.; Guyton, John R.; Knopp, Robert H.
In: Journal of Clinical Lipidology, Vol. 3, No. 2, 04.2009, p. 65-69.Research output: Contribution to journal › Comment/debate
TY - JOUR
T1 - The use of niacin†
AU - Brown, W. Virgil
AU - Goldberg, Anne C.
AU - Guyton, John R.
AU - Knopp, Robert H.
N1 - Funding Information: This roundtable discussion was supported by an unrestricted grant from Abbott Laboratories, Abbott Park, IL. Funding Information: Dr. Brown is an advisor to AstraZeneca, Wilmington, DE; Bristol-Myers Squibb, New York, NY; Eli Lilly, Indianapolis, IN; Kos Pharmaceuticals, Weston, FL; Merck, Whitehouse Station, NJ; Merck/Shering-Plough, Whitehouse Station, NJ; Pfizer, New York, NY; Reliant Pharmaceuticals, Liberty Corner, NJ; and Unilever, Englewood Cliffs, NJ. Dr. Brown has received education or research grants from Abbott; AstraZeneca; Eli Lilly; Kos; Pfizer; and Takeda Pharmaceuticals, Deerfield Park, IL. Dr. Brown is a member of the speaker's bureaus of Abbott; AstraZeneca; Bristol-Myers Squibb; Kos; Lilly; Merck; Merck/Shering-Plough; Pfizer; Reliant; and Takeda. Dr Goldberg has received research grants from Abbott; AstraZeneca; Kos; Merck; Pfizer; Reliant; Sankyo Pharmaceuticals, Parsippany, NJ; Sanofi-Aventis, Bridgewater, NJ; and Takeda. Dr. Goldberg has received consulting fees from Abbott and Unilever, Englewood Cliffs, NJ. Dr Guyton has received education or research grants from AstraZeneca; Isis Pharmaceuticals, Carlsbad, CA, Merck; Pfizer; and Schering-Plough. Dr. Guyton is a member of the speaker's bureau of Merck. Dr Knopp is an advisor to Abbott; Clinical Advisors, New York, NY; and NexCura, Seattle, WA. Dr. Knopp is a member of the speaker's bureau of Access Medical Group, Chicago, IL; AstraZeneca; and Medical Education Group, Trevose, PA.
PY - 2009/4
Y1 - 2009/4
UR - http://www.scopus.com/inward/record.url?scp=61949381637&partnerID=8YFLogxK
U2 - 10.1016/j.jacl.2009.02.010
DO - 10.1016/j.jacl.2009.02.010
M3 - Comment/debate
C2 - 21291794
AN - SCOPUS:61949381637
VL - 3
SP - 65
EP - 69
JO - Journal of Clinical Lipidology
JF - Journal of Clinical Lipidology
SN - 1933-2874
IS - 2
ER -